Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI-Powered imaging could revolutionize anemia diagnosis

NCT ID NCT05282888

First seen Jun 23, 2026 · Last updated Jun 23, 2026

Summary

This study tested a new way to analyze red blood cells in people with anemia using flow imaging and artificial intelligence. Instead of the usual method of spreading blood on a slide and staining it, the researchers used a machine that takes pictures of cells flowing in liquid. They built a database of normal and abnormal red blood cell shapes to train an AI. The goal was to see if this automated method could match the accuracy of traditional manual analysis, potentially making diagnosis faster and more consistent.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU Amiens Picardie

    Amiens, Picardie, 80054, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a faster, more objective way to diagnose anemias using AI and imaging, reducing reliance on manual blood smear analysis.

What could go wrong

This is a small, completed study with only 14 participants, focused on building a database. It does not test a treatment, and the AI method may not yet be ready for routine clinical use.

Conditions

The condition(s) this trial relates to.

Sickle Cell Trait

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.